|
⚲
|
| Keyboard |
| Osorio Benedict
✚
|
|
|---|---|
| CIK # | 0001732730 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001732730] | |
| 4 | [0001732730] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Provention Bio Inc | |
| Osorio Benedict | |
| Progenics Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Provention Bio Inc PRVB
Option to Purchase Common Stock · derivative
|
2023-04-27 | Disposed to issuer | 100,000 | ||
|
Provention Bio Inc PRVB
Option to Purchase Common Stock · derivative
|
2023-04-27 | Disposed to issuer | 187,000 | ||
|
Provention Bio Inc PRVB
Option to Purchase Common Stock · derivative
|
2023-04-27 | Disposed to issuer | 80,000 | ||
|
Provention Bio Inc PRVB
Option to Purchase Common Stock · derivative
|
2023-04-27 | Disposed to issuer | 70,000 | ||
|
Provention Bio Inc PRVB
Stock Option (right to buy) · derivative
|
2023-01-10 | Grant | 187,000 | $0.00 | |
|
Provention Bio Inc PRVB
Stock Option (right to buy) · derivative
|
2022-12-08 | Grant | 18,000 | $0.00 | |
|
Provention Bio Inc PRVB
Stock Option (right to buy) · derivative
|
2022-05-17 | Grant | 9,000 | $0.00 | |
|
Provention Bio Inc PRVB
Stock Option (right to buy) · derivative
|
2022-01-18 | Grant | 80,000 | $0.00 | |
|
Progenics Pharmaceuticals Inc PGNX
Common Stock
|
2020-06-19 | Disposed to issuer | 21,202 | ||
|
Progenics Pharmaceuticals Inc PGNX
Stock Option (Right to Buy) · derivative
|
2020-06-19 | Disposed to issuer | 82,214 | ||
|
Progenics Pharmaceuticals Inc PGNX
Stock Option (Right to Buy) · derivative
|
2020-06-19 | Disposed to issuer | 100,000 | ||
|
Progenics Pharmaceuticals Inc PGNX
Stock Option (Right to Buy) · derivative
|
2020-06-19 | Disposed to issuer | 90,750 | ||
|
Progenics Pharmaceuticals Inc PGNX
Non-Qualified Stock Option (Right to Buy) · derivative
|
2020-03-02 | Grant | 82,214 | $0.00 | |
|
Progenics Pharmaceuticals Inc PGNX
Non-Qualified Stock Option (Right to Buy) · derivative
|
2019-03-01 | Grant | 90,750 | $0.00 | |
|
Progenics Pharmaceuticals Inc PGNX
Non-Qualified Stock Option (Right to Buy) · derivative
|
2018-03-01 | Grant | 100,000 | $0.00 |